Fried Frank acted as counsel to Becton, Dickinson and Company [NYSE:BDX] in its acquisition of TVA Medical. The acquisition of the Austin, Texas-based company, which develops minimally invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis, will improve Becton Dickinson's ability to serve physicians and their patients by providing a minimally invasive option for such procedures. Becton Dickinson used cash on hand to finance the transaction, but further financial details, as well as the terms of the transaction, were not disclosed. This transaction is not expected to have a material impact on Becton Dickinson financial results for fiscal 2018 or 2019.
The Fried Frank team was led by corporate partner Steven Epstein and included executive compensation & ERISA partner Adam Kaminsky; litigation partner Joshua D. Roth; tax partner Michael J. Alter; corporate special counsel Howard A. Fine; corporate associates Christopher S. Celentano, Asad Hussain, and Roy Tannenbaum; environmental associates Samuel K. Dykstra and Mary Beth Phipps; executive compensation & ERISA associate Maggie A. Kornreich; intellectual property and technology associate Marli Sussman; litigation associate Adam Y. Yefet; tax associate Thomas A. Mitchell; and corporate law clerks Mehar Najeeb and Michael G. Riyad.